image

The best stocks to buy since 1993

Latest issue now available

SIGN UP NOW
Updates and Ideas

Bio Focus - Nomura 600p share price target

March 2002

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • BIO
In a stockmarket dazzled by very little at the moment, a company with its main business providing chemistry and biology outsourcing services to the pharmaceutical industry, does not immediately catch theeye. But BioFocus (300p), established as recently as 1997 by four scientists from the Wellcome research facilities in Beckenham, looks attractive at the current price. Until last year, thecompany's main business was the provision of fee-based combinatorialchemistry services (compound design and synthesis for specifictargets) to support new drug discovery and development of compounds atthe pre-clinical stage. A drug discovery process relies ondeveloping an assay (a diagnostic test that mimics the disease) andthen usin ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe

SUBSCRIBE NOW